30 May 2012 10:03
30 May 2012
Regenersis plc
("Regenersis" or the "Company")
Director/PDMR Shareholding
Regenersis plc (the 'Company'), a strategic outsourcing partner to many of the world's leading consumer technology companies, received notification on 28 May 2012 of the following director dealing in the ordinary shares of 2 pence each in the Company ("Shares").
On 25 May 2012, Hanover Investment Partners - IX LLC acquired 50,000 Shares. The purchase price of these shares was 91.55 pence per Share.
On 28 May 2012, Hanover Investment Partners - IX LLC acquired 250,000 Shares. The purchase price of these shares was 92.875 pence per Share.
Matthew Peacock, Chairman of Regenersis, as a partner in Hanover Investors Management LLP, has an indirect beneficial interest in these shares. The combined resultant holding of Hanover Investors Management LLP and its connected parties is 10,138,351 ordinary shares equating to 22.62 per cent. of the issued share capital of the Company.
Enquiries:
Regenersis plc +44 (0)20 7766 8400
Jog Dhody
Arden Partners plc (Nomad and Joint Broker) +44 (0)121 423 8900
Steve Douglas
Panmure Gordon (UK) Limited (Joint Broker) +44 (0)20 7459 3600
Dominic Morley / Brett Jacobs
FTI Consulting +44 (0)20 7831 3113
Matt Dixon / Charles Palmer / Jon Snowball
Ends